Oxygen therapy may boost stem cells – new study investigates
NCT ID NCT06748586
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will measure how hyperbaric oxygen therapy (HBOT) changes the number of stem cells in the blood of 60 adults aged 20 to 80 who are already scheduled to receive HBOT for other medical reasons. Researchers will take blood samples at different times during treatment to count specific stem cell markers. The goal is to understand the body's response to HBOT, not to treat any disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRCULATING HEMATOPOIETIC STEM CELLS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh)
RECRUITINGZrifin, 70300, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••